Verma N K, Ziegler H K, Wilson M, Khan M, Safley S, Stocker B A, Schoolnik G K
Howard Hughes Medical Institute, Stanford University School of Medicine, CA 94305, USA.
Vaccine. 1995 Feb;13(2):142-50. doi: 10.1016/0264-410x(95)93127-u.
Using a Salmonella vaccine-Listeria infection model of intracellular infection, we studied the capacity of an attenuated strain of Salmonella carrying T-cell epitopes of listeriolysin (LLO) of L. monocytogenes to elicit epitope-specific T-cell responses. Class II (LLO 215-226) or class I (LLO 91-99) MHC-restricted T-cell epitopes of LLO were inserted within a central, hypervariable domain of the flagellin protein of an attenuated delta aroA Salmonella dublin strain. T cells from Listeria-immunized mice were activated by lysates or heat-killed preparations of Salmonella construct expressing the LLO 215-226 epitope, indicating that LLO 215-226 is processed and presented to T cells when offered to antigen-presenting cells as part of a flagellin-epitope fusion protein. The chimeric flagellin genes were integrated into the chromosome of the flagellin-negative S. dublin strain to obtain stable expression of the epitopes. Immunization with the living, chromosomally integrated Salmonella construct carrying LLO 215-226 epitope as part of the flagellin protein generated T cells reactive with the corresponding LLO peptide, indicating that this chimera can stimulate a class-specific immune response in vitro. The effect of flanking residues on the processing and presentation of MHC class I LLO 91-99 epitope was studied using Salmonella vaccine strains that express chimeric flagellins containing one of three LLO 91-99 inserts: 91-99 (normal flagellin amino acids as flanking residues); KK91-99KK (Lys-Lys flanking residues); and AAA91-99AAA (Ala-Ala-Ala flanking residues).(ABSTRACT TRUNCATED AT 250 WORDS)
利用沙门氏菌疫苗-单核细胞增生李斯特菌细胞内感染模型,我们研究了携带单核细胞增生李斯特菌溶血素(LLO)T细胞表位的减毒沙门氏菌菌株引发表位特异性T细胞应答的能力。LLO的II类(LLO 215-226)或I类(LLO 91-99)MHC限制性T细胞表位被插入减毒的缺失aroA基因的都柏林沙门氏菌鞭毛蛋白的一个中央高变区内。来自李斯特菌免疫小鼠的T细胞被表达LLO 215-226表位的沙门氏菌构建体的裂解物或热灭活制剂激活,这表明当作为鞭毛蛋白-表位融合蛋白提供给抗原呈递细胞时,LLO 215-226被加工并呈递给T细胞。嵌合鞭毛蛋白基因被整合到鞭毛蛋白阴性的都柏林沙门氏菌菌株的染色体中,以获得表位的稳定表达。用作为鞭毛蛋白一部分携带LLO 215-226表位的活的、染色体整合的沙门氏菌构建体免疫产生了与相应LLO肽反应的T细胞,这表明这种嵌合体可以在体外刺激类特异性免疫应答。使用表达含有三种LLO 91-99插入物之一的嵌合鞭毛蛋白的沙门氏菌疫苗菌株研究了侧翼残基对MHC I类LLO 91-99表位加工和呈递的影响:91-99(正常鞭毛蛋白氨基酸作为侧翼残基);KK91-99KK(赖氨酸-赖氨酸侧翼残基);和AAA91-99AAA(丙氨酸-丙氨酸-丙氨酸侧翼残基)。(摘要截短于250字)